Schutz CG, Vlahov D, Anthony JC, Graham NM. 1994. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. Journal of Clinical Epidemiology. 47:191–195.
Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O’Grady KE, Battjes RJ. 2006. A randomized controlled trial of interim methadone maintenance. Archives of General Psychiatry. 63(1):102–109.
Scorzelli JF. 1992. Has Malaysia’s antidrug effort been effective. Journal of Substance Abuse Treatment. 9(2):171–176.
Secades-Villa R, Fernande-Hermida JR, Arnaez-Montaraz C. 2004. Motivational interviewing and treatment retention among drug user patients: A pilot study. Substance Use and Misuse. 39(9):1369–1378.
Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM. 2000. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. Journal of the American Medical Association. 283(10):1303–1310.
Sellman JD, Sullivan PF, Dore GM, Adamson SJ, MacEwan I. 2001. A randomized controlled trial of Motivational Enhancement Therapy (MET) for mild to moderate alcohol dependence. Journal of Studies on Alcohol. 62:389–396.
Serpellini G, Carrieri MP. 1994. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested case-control study. AIDS Care. 6(2):215–220.
Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, Freese TE, Hucks-Ortiz C. 2005. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence. 78:125–134.
Shoptaw S, Huber A, Peck J, Yang X, Liu J, Dang J, Roll J, Shapiro B, Rotheram-Fuller E, Ling W. 2006. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug and Alcohol Dependence. 85(1):12–18.
Shufman EN, Porat S, Witzum E, Gandacu C, Bar-Hamburger R, Ginath Y. 1994. The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry. 35(12):935–945.
Simpson DD, Joe GW, Rowan-Szal G, Greener J. 1995. Client engagement and change during drug abuse treatment. Journal of Substance Abuse. 7:117–134.
Soares BGO, Lima MS, Lima Reisser A, Farrell M. 2003. Dopamine agonists for cocaine dependence. The Cochrane Database of Systematic Reviews. (2):CD003352.
Sorenson JL, Copeland AL. 2000. Drug abuse treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence. 59:17–31.
Sorensen JL, London J, Heitzmann C, Gibson DR, Morales E, Dumontet R, Acree M. 1994. Psychoeducational group approach: HIV risk reduction in drug users. AIDS Education and Prevention. 6:95–112.
Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. 2001. Treatment for amphetamine dependence and abuse. The Cochrane Database of Systematic Reviews. (4):CD003022.
Stark K, Muller R, Bienzle U, Guggenmoos-Holzmann I. 1996. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin. Journal of Epidemiology and Community Health. 50:534–537.
Stotts AL, Schmitz JM, Rhoades HM, Grabowski J. 2001. Motivational interviewing with cocaine-dependent patients: A pilot study. Journal of Consulting and Clinical Psychology. 69(5):858–862.
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. 1993. Dose-response effects of methadone in the treatment of opioid dependence. Annals of Internal Medicine. 119:23–27.